You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
This Podcast features a conversation with the senior author of a Research Article published in the March 29 issue of Science Signaling. Thomas Graeber discusses his group’s phosphoproteomic analysis of a leukemia cell line, which reveals a mechanism by which leukemia cells may become resistant to chemotherapeutic agents that target tyrosine kinases. They found that the sensitivity of leukemias driven by the Bcr-Abl fusion protein to tyrosine kinase inhibitors depends on the cells’ reliance on negative feedback mechanisms that limit the activity of the Src family of tyrosine kinases.